You just read:

Allergan and Adamas Announce New Expanded Indication for NAMZARIC® (Memantine and Donepezil Hydrochlorides) Extended Release for the Treatment of Moderate to Severe Alzheimer's Disease

News provided by

Allergan plc

Jul 19, 2016, 07:59 ET